CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
about
Targeting the latent reservoir to achieve functional HIV cureGenome-Edited T Cell Therapies.Genome editing and the next generation of antiviral therapy.In vivo disruption of latent HSV by designer endonuclease therapyGene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.Developmental history and application of CRISPR in human disease.Recent Advances in CRISPR-Cas9 Genome Editing Technology for Biological and Biomedical Investigations.CRISPR Editing Technology in Biological and Biomedical Investigation.Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks.A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication.Cell and gene therapy strategies to eradicate HIV reservoirsCRISPR: express delivery to any DNA address.Stem cell-based therapies for HIV/AIDS.Therapeutic applications of CRISPR RNA-guided genome editing.Nuclear landscape of HIV-1 infection and integration.Novel AIDS therapies based on gene editing.The therapeutic landscape of HIV-1 via genome editingCan the HIV-1 splicing machinery be targeted for drug discovery?CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication.Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.Excision of Latent HIV-1 from Infected Cells In Vivo: An Important Step Forward.In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.Disruption or Excision of Provirus as an Approach to HIV Cure.Clinical Applications of Genome Editing to HIV Cure.CRISPR/Cas9: a double-edged sword when used to combat HIV infection.CRISPR/Cas9-Mediated Immunity to Geminiviruses: Differential Interference and Evasion.The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa.Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.The Future of Multiplexed Eukaryotic Genome Engineering.CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.Synthetic AAV/CRISPR vectors for blocking HIV-1 expression in persistently infected astrocytes.Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy.Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.CRISPR/Cas9: the Jedi against the dark empire of diseases.
P2860
Q26745923-66861254-E689-4FDC-A21F-5B6C4C9B84E9Q33729598-0450D990-FFBB-4FA1-A990-E259B9BBE887Q34529971-A6DEDB18-09D9-47FF-B250-F202CCDD4182Q34540648-A80D2F2C-9F90-43A5-BF9A-51251D9FE861Q36216276-0A2724E7-57C5-4C5C-8482-33CF92BBF08BQ37086989-AABC330C-C4C2-49A6-A5B3-49B3857A4788Q37177251-017AFDD3-1AF3-49B7-AA7C-8F5946306460Q38669948-E419C730-D792-4D4C-9A63-27E80D5540CDQ38679054-53AEE0E8-6E56-4922-A7C3-FA900089F830Q38688945-1BB831D3-BC1E-47CD-BAA2-0B74F25F49B0Q38700030-A94DFAD0-E1CB-4071-83FA-7D15579D1A0FQ38759997-76EE2F94-06A8-4E58-B363-6CC61F842492Q38765734-B4A31887-F956-4540-9B16-6E329BC2EF93Q38794293-AB8F7C49-AF54-41D4-9C21-771682064839Q38797121-D0724057-86B7-4B9C-8AAD-A768F7A63133Q38827119-C1D7143C-00C0-4C1A-A407-12764906E08EQ38937607-87E0B2CF-8B87-4674-9DEB-5A92B0959208Q39035944-A245B272-EB36-4E7F-863D-FB0D5925C4DCQ39140209-54279D7E-9F74-477B-AF21-A408664F115CQ39153976-ADAE2082-D713-4533-91D9-3FF38B1052A9Q39194586-5707452E-4946-41C8-AE9F-F91E2D89AC95Q40044279-84D4C3A7-DE15-48AC-9439-52A18EF795DDQ40046785-F72E5C68-0528-49E8-B874-392DCA9E7A61Q40230137-BD7B2594-E49C-408A-820F-1C350593E5D2Q40263108-6D2BADE2-B192-432E-AB63-91E56BBB3397Q40448071-F36398BD-9CF1-4065-9A53-3AC8A8F3FD29Q40448468-BD36F4F5-62BE-46F1-8255-49CF4821914AQ40657354-D3F694D0-0848-4826-B2F1-615BE9AEE4FCQ40659541-41C92DC1-6BA1-4E39-8F23-2E9DBAACEFDDQ42380882-139F40DC-99BA-4151-85A0-5C86C7FEEC81Q43212335-1D7813C6-ADF1-4F34-8B81-33528A924498Q47249662-1762BD5D-AA9E-46B8-A521-6002D5DBD2EFQ47275614-CBC91428-A01D-4353-B859-D725A0A8252DQ47585560-D179BBDB-12DE-4343-89B4-8FD60ABA66ABQ49462231-F3EC3A81-508E-4C03-9B49-B8E1B98912F8Q49980151-1EF2F6EB-2C9D-4720-8D45-78E6D6BF4F46Q50878341-1C69D8DD-C569-4A3B-B1F7-69F1AAAA01AEQ52430698-CBD7CBED-C9F2-47AF-A1C3-A290A5D5AA54Q52431127-749BB4BC-B037-47C5-98EF-7A4700C522B2Q55263970-30496C40-3402-415E-AD1A-75C1518B725C
P2860
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
@en
type
label
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
@en
prefLabel
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
@en
P2093
P2860
P356
P1433
P1476
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
@en
P2093
P2860
P304
P356
10.1038/MT.2016.24
P577
2016-01-22T00:00:00Z